AIDS
- DIETERICH DT, Brunet L, Hsu RK, Mounzer K, et al
Tenofovir interruption among people with HIV and HBV: HBV monitoring and risk of
HBV reactivation and hepatitis flare.
AIDS. 2025 Sep 19. doi: 10.1097/QAD.0000000000004353.
Am J Gastroenterol
- TILLMANN HL
Finite Treatments for Viral Hepatitis: Is "Sustained Control" Versus Cure
Acceptable for HBV?
Am J Gastroenterol. 2025 Sep 19. doi: 10.14309/ajg.0000000000003719.
Arch Virol
- PENG D, Hu X, Huang J, Li Q, et al
Coordinated role of RIG-I, MDA5, and TLR7 in the innate immune response to duck
hepatitis A virus 3.
Arch Virol. 2025;170:211.
BMJ
- TANNE JH
US vaccine committee changes MMR and hepatitis vaccine schedules amid criticism.
BMJ. 2025;390:r1992.
Clin Infect Dis
- LO RE V 3RD, Bhattacharya D, Price JC, Aronsohn A, et al
State-of-the-Art Review: Hepatitis C.
Clin Infect Dis. 2025;81:e15-e26.
- LO RE V 3RD, Bhattacharya D, Price J, Aronsohn A, et al
Executive Summary: State-of-the-Art Review: Hepatitis C.
Clin Infect Dis. 2025;81:217-219.
Eur J Gastroenterol Hepatol
- HUANG X, Wang H, Hu J, Cai M, et al
Development of a retinal vascular nomogram for predicting hepatitis B
virus-related cirrhosis: insights into extrahepatic microcirculatory
dysfunctions.
Eur J Gastroenterol Hepatol. 2025 Sep 17. doi: 10.1097/MEG.0000000000003078.
J Viral Hepat
- SALAMANCA BV, Johannessen A, Dalgard O, Whittaker R, et al
Linkage to Care, Retention in Care and Treatment Uptake Among Patients Diagnosed
With Chronic Hepatitis B in Norway, 2008-2022.
J Viral Hepat. 2025;32:e70089.
J Virol
- MATSUI C, Yuliandari P, Deng L, Abe T, et al
Hepatitis C virus NS3/4A protease cleaves SPG20, a key regulator of lipid droplet
turnover, to promote lipid droplet formation.
J Virol. 2025 Sep 23:e0089025. doi: 10.1128/jvi.00890.
Pediatr Infect Dis J
- POKORSKA-SPIEWAK M, Dobrzeniecka A, Talarek E, Aniszewska M, et al
Comparison of Noninvasive Methods for the Evaluation of Liver Fibrosis in
Children With Chronic Hepatitis C Virus Infection.
Pediatr Infect Dis J. 2025 Sep 11. doi: 10.1097/INF.0000000000004978.
PLoS Pathog
- MEHNERT AK, Stegmaier S, Ramirez Alvarez C, Toprak E, et al
The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral
responses to enable persistent replication in cell culture.
PLoS Pathog. 2025;21:e1013516.
Virology
- MURAYAMA A, Yamada N, Toyama M, Aly HH, et al
A synonymous mutation in the preS2 region enhances production of infectious
hepatitis B virus.
Virology. 2025;612:110692.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016